NCT04900610View on ClinicalTrials.gov

The Effect of Vitamin K2 Supplementation on Arterial Stifness and Cardiovascular Events in PEritonial DIAlysis

NAUnknownINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

September 30, 2022

Conditions

Vitamin K DeficiencyEnd Stage Renal DiseasePeritoneal DialysisArterial StiffnessCardiovascular MorbidityMortality

Interventions

DIETARY_SUPPLEMENT

MenaQ7 ®, Nattopharma, ASA, Hovik, Norway

daily per os supplementation of 1mg MK-7

Sponsors

Collaborators (1)

Nattopharma ASA

All Listed Sponsors

collaborator

Nattopharma ASA

INDUSTRY

lead

Aristotle University Of Thessaloniki

OTHER

NCT04900610 - The Effect of Vitamin K2 Supplementation on Arterial Stifness and Cardiovascular Events in PEritonial DIAlysis | Biotech Hunter | Biotech Hunter